Remove Medicine Remove Packaging Remove Pharma Production Remove Production
article thumbnail

Foods, supplements, and medicine: the new frontier in chronic disease treatment

pharmaphorum

Salt and sugar are proven to inhibit specific pathways and prevent absorption of a whole package of nutrients important for childhood development. However, medicine has traditionally focused on symptom management, rather than holistically targeting the root cause of the disease. What’s the fix? READ THE REST OF THE ARTICLE HERE.

article thumbnail

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

Compared with other emerging pharmaceutical markets (such as India and China, covered in previous Emerging Market Outsourcing Reports), Russian facilities lack many US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals, meaning Russian manufacturing is more focused on the domestic market.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cardiac and Diabetic PCD Pharma Franchise Company in India

Fossil Remedies

As the number of people affected by these problems is increasing, there is a high demand for medicines required to treat them. If you are planning to launch Cardiac Diabetic PCD Pharma Franchise, then it is the best time. Choose a company that offers the best quality cardiac and diabetic medicines.

article thumbnail

PCD Pharma Franchise Andhra Pradesh

Creogenic Pharma

250+ Products. PCD Pharma Franchise in Andhra Pradesh: Creogenic pharma is an ISO 9001:2008 accredited top pharma franchise firm. Our products are produced from the WHO and GMP accredited production units. Our products are produced from the WHO and GMP accredited production units. Lowest Price.

article thumbnail

Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

SUS provides full, free and universal access to healthcare for the country's entire population (215 million), which spends around 10% of its gross domestic product (GDP) on healthcare. Only a limited number of international pharma companies, however, operate manufacturing sites in the country.

article thumbnail

‘Right shoring’ API production in Europe

Pharmaceutical Technology

Only 25% of API production for generic drugs took place in Europe in 2020, according to a November 2022 Medicines for Europe report. For innovative medicines, this share was 77%. Sanofi and Astra Zeneca have also announced plans for new API production plants in Europe.” For example, Roche and GlaxoSmithKline in the UK.

article thumbnail

The impact of climate change on the pharma supply chain

Pharmaceutical Technology

And delays in the supply chain, even for short periods of time can potentially affect the efficacy of medicines, lead to longer-term supply bottlenecks, and ultimately prevent people from getting access to the critical medicines they need. Pharma manufacturing can also be affected by extreme weather events, such as storms.